Results 11 to 20 of about 21,716,016 (301)
High Dose-Rate Versus Low Dose-Rate Brachytherapy for Lip Cancer
International Journal of Radiation Oncology*Biology*Physics, 2012 To analyze the outcome after low-dose-rate (LDR) or high-dose-rate (HDR) brachytherapy for lip ...Jens O. Brömme, Daniel M. Aebersold, Geretschläger, Andreas, Pica, Alessia, Bernhard Isaak, Beat Bojaxhiu, Brömme, Jens O, Aebersold, Daniel M, Ghadjar, Pirus, Simcock, Mathew, Isaak, Bernhard, Gut, Philipp, Wolfensberger, Patrick, Dario Terribilini, Bojaxhiu, Beat, Terribilini, Dario, Philipp Gut, Behrensmeier, Frank, Mathew Simcock, Alessia Pica, Patrick Wolfensberger, Pirus Ghadjar, Frank Behrensmeier, Andreas Geretschläger, Terribilini D, Aebersold DM, Gut P, Isaak B, Brömme JO, Brömme, Jens, Pica A, Behrensmeier F, Bojaxhiu B, Aebersold, Daniel Matthias, Geretschläger A, Wolfensberger P, Wolfensberger, Patrick Rudolf, Simcock M, Ghadjar P +38 morecore +5 more sourcesSecond salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer [PDF]
Journal of Contemporary Brachytherapy, 2017 Purpose : Salvage treatments for localized radiorecurrent prostate cancer can be performed safely when a focal and image guided approach is used. Due to the low toxicity, the opportunity exists to investigate a second salvage treatment when a second ...Metha Maenhout, Marco van Vulpen, Marinus Moerland, Max Peters, Richard Meijer, Maurice van den Bosch, Paul Nguyen, Steven Frank, Jochem van der Voort van Zyp +8 moredoaj +2 more sourcesUnderstanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation Therapy. [PDF]
International Journal of Radiation Oncology*Biology*Physics, 2020 The National Cancer Institute's Radiation Research Program, in collaboration with the Radiosurgery Society, hosted a workshop called Understanding High-Dose, Ultra-High Dose Rate and Spatially Fractionated Radiotherapy on August 20 and 21, 2018 to bring ...Formenti, Sylvia C, Snider, James W., Mayr, Nina A., Petersson, Kristoffer, Welsh, James, Chang, Sha, Abdel-Wahab, May, Amendola, B., Maxim, P.G., Abdel-Wahab, M., Djonov, Valentin, Maxim, Peter G., Belyakov, O., Bentzen, Søren M., Simone, Charles B., II, Griffin, R.J., Obcemea, C., Butterworth, Karl T, Loo, Billy W., Jr., Vozenin, Marie-Catherine, Coleman, C Norman, Spitz, Douglas R, Loo, Billy W, Snider, J.W., Spitz, D.R., Vozenin, M.C., Limoli, Charles L, Simone, Charles B (2nd), Griffin, Robert J., Bentzen, Søren M, Ahmed, Mansoor M., Romanelli, P., Mohiuddin, Mohammed, Wu, X., Guha, Chandan, Coleman, C.N., Mahadevan, A., Vikram, B., Formenti, S.C., Ahmed, Mansoor M, Mohiuddin, Majid, Mahadevan, Anand, Loo, B.W., Belyakov, Oleg, Bentzen, S.M., Simone, Charles B, Griffin, Robert J, Le, Q.T., Guha, C., Wu, Xiaodong, Amendola, Beatriz, Maxim, Peter G, Regine, William, Massaccesi, M., Massaccesi, Mariangela, Loo, Billy W (Jr), Ahmed, M.M., Mayr, N.A., Vikram, Bhadrasain, Limoli, Charles L., Coleman, C. Norman, Djonov, V., Mohiuddin, M., Petersson, K., Simone, C.B., Butterworth, K.T., Mayr, Nina A, Obcemea, Ceferino, Snider, James W, Romanelli, Pantaleo, Butterworth, Karl T., Glatstein, E., Glatstein, Eli, Spitz, Douglas, Welsh, J., Formenti, Sylvia C., Chang, S., Kalnicki, Shalom, Regine, W., Kalnicki, S., Le, Quynh-Thu, Roach, M., Roach, Mack, Limoli, C.L., Petersson K, Ahmed MM, Amendola B, Maxim PG, Griffin RJ, Guha C, Djonov V, Loo BW, Mayr NA, Glatstein E, Romanelli P, Snider JW, Bentzen SM, Le QT, Roach M, Butterworth KT, Chang S, Limoli CL, Coleman CN, Kalnicki S, Regine W, Abdel-Wahab M, Wu X, Vozenin MC, Formenti SC, Djonov, Valentin Georgiev, Welsh J, Obcemea C, Vikram B, Spitz DR, Mahadevan A, Simone CB, Belyakov O, Massaccesi M, Mohiuddin M +118 morecore +4 more sourcesComparison of two high dose rate brachytherapy regimes
Journal of Pharmacy and Bioallied Sciences, 2023 Background: Two HDR brachytherapy regimes were compared, 9.5 Gray per fraction for two fractions and 7.5 Gray per fraction for three fractions. Materials and Methods: A total of 80 patients with histologically evident squamous cell carcinoma cervix were ...Gaurav Jaswal, Raja Benipal, Seema G Bhatty, Pardeep Garg, Manraj S Kang +4 moredoaj +3 more sourcesDose determination in high dose-rate brachytherapy
International Journal of Radiation Oncology*Biology*Physics, 1992 Although high dose-rate brachytherapy with a single, rapidly moving radiation source is becoming a common treatment modality, a suitable formalism for determination of the dose delivered by a moving radiation source has not yet been developed. At present,Abitbol, Andre A, Braunschweiger, Paul G, Serago, Christopher F, Pisciotta, Vincent, Sklar, Marshall D, Wu, Xiaodong, Fiedler, Jeffrey A, Lewin, Alan A, Markoe, Arnold M, Houdek, Pavel V, Schwade, James G, James G. Schwade, Paul G. Braunschweiger, Alan A. Lewin, Vincent Pisciotta, Andre A. Abitbol, Jeffrey A. Fiedler, Marshall D. Sklar, Xiaodong Wu, Christopher F. Serago, Pavel V. Houdek, Arnold M. Markoe +21 morecore +3 more sourcesHigh-dose-rate brachytherapy in the treatment of skin Kaposi sarcoma
Journal of Contemporary Brachytherapy, 2017 Purpose : The aim of the study is to review our experience in treatment of Kaposi sarcoma (KS) lesions with high-dose-rate (HDR) brachytherapy.
Material and methods : We present five new KS lesions (three patients) that were treated in our hospital ...María Ángeles González Ruiz, Juan Quirós Rivero, Julia Luisa Muñoz García, Joaquín José Cabrera Rodríguez, Yesika Ríos Kavadoy, María Francisca Ropero Carmona, Almudena Corbacho Campos, Fernando García Urra, María Cristina Cruz Muñoz, Amanda Ruiz Herrero, Pedro Almendral Manzano +10 moredoaj +2 more sourcesDefinitive three-dimensional high-dose-rate brachytherapy for inoperable endometrial cancer [PDF]
Journal of Contemporary Brachytherapy, 2017 Purpose : To report our experience on high-dose-rate brachytherapy (HDR-BT) in patients with stage I-III endometrial cancer unfit to surgery.
Material and methods : Seventeen patients underwent HDR-BT as definitive treatment.Lorena Draghini, Ernesto Maranzano, Michelina Casale, Fabio Trippa, Paola Anselmo, Fabio Arcidiacono, Stefania Fabiani, Marco Italiani, Luigia Chirico, Marco Muti +9 moredoaj +2 more sourcesAdjuvant high dose rate brachytherapy for soft tissue sarcomas: initial experience report
Journal of Contemporary Brachytherapy, 2011 Purpose: Adjuvant high-dose-rate brachytherapy (HDRBT) offers advantages over low dose rate brachytherapy (LDRBT), although there are little data on local tumor control and treatment related toxicity. We report outcome in patients with primary, recurrent,Robert Whitfield, Dian Wang, Donald Hackbarth, David King, Sara H. Kleinman, Jason Rownd, Julie A. Bradley +6 moredoaj +1 more source